Medicare Enrolled

Dr. Sami Arslanlar, MD

Gastroenterology · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
8220 WALNUT HILL LN STE 710, Dallas, TX 75231
2143686707
In practice since 2007 (19 years)
NPI: 1033235684 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Arslanlar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arslanlar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Arslanlar

Dr. Sami Arslanlar is a gastroenterology in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Arslanlar performed 848 Medicare services across 769 unique beneficiaries.

Between the years covered by Open Payments, Dr. Arslanlar received a total of $127,747 from 43 pharmaceutical and/or device companies across 1055 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Arslanlar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 32% volume in TX$ $127,747 industry payments

Medicare Practice Summary

Medicare Utilization ↗
848
Medicare services
Top 32% in TX for gastroenterology
769
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~45 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)188$61$148
Colonoscopy with biopsy137$134$847
Upper GI endoscopy with biopsy132$53$680
Office visit, established patient (30-39 min)119$89$217
Removal of polyps or growths of large bowel using an endoscope with mechanical snare69$201$1,067
Colorectal cancer screening; colonoscopy on individual at high risk54$173$778
New patient office visit (45-59 min)43$118$332
Insertion of guide wire with dilation of esophagus using a flexible endoscope39$97$701
New patient office visit (30-44 min)21$81$219
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk18$178$781
New patient office or other outpatient visit, 15-29 minutes16$51$151
Diagnostic exam of large bowel using a flexible endoscope12$142$781
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$127,747
Total received (2018-2024)
Avg $18,250/year across 7 years
Top 3% in TX for gastroenterology
43
Companies
1,055
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$119,580 (93.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,167 (6.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$24,195
2023
$21,967
2022
$11,734
2021
$10,510
2020
$12,363
2019
$26,581
2018
$20,398

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AbbVie, Inc.
$44,932
AbbVie Inc.
$42,283
ABBVIE INC.
$32,365
Takeda Pharmaceuticals U.S.A., Inc.
$1,593
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$716
Janssen Biotech, Inc.
$682
Merck Sharp & Dohme LLC
$449
GENZYME CORPORATION
$431
Regeneron Healthcare Solutions, Inc.
$367
Celgene Corporation
$358
PFIZER INC.
$327
QOL Medical, LLC
$285
UCB, Inc.
$253
Ferring Pharmaceuticals Inc.
$248
INTERCEPT PHARMACEUTICALS, INC.
$203
Synergy Pharmaceuticals Inc
$176
Daiichi Sankyo Inc.
$169
Shionogi Inc
$157
SHIELD THERAPEUTICS INC
$149
RedHill Biopharma Inc.
$148
Lilly USA, LLC
$145
Ironwood Pharmaceuticals, Inc
$144
Fresenius Kabi USA, LLC
$136
Ardelyx, Inc.
$124
Intercept Pharmaceuticals, Inc.
$106
Celltrion USA Inc.
$103
Allergan Inc.
$99
EVOKE PHARMA, INC.
$93
Sandoz Inc.
$63
Nestle HealthCare Nutrition Inc.
$58
Madrigal Pharmaceuticals
$54
Braintree Laboratories, Inc.
$50
Evoke Pharma, Inc.
$44
Phathom Pharmaceuticals, Inc.
$38
Merck Sharp & Dohme Corporation
$33
AstraZeneca Pharmaceuticals LP
$33
Endo Pharmaceuticals Inc.
$27
Shire North American Group Inc
$20
Ipsen Biopharmaceuticals, Inc
$20
Ethicon US, LLC
$19
Perspectum Diagnostics Ltd
$18
Gilead Sciences, Inc.
$14
Micro-tech Endoscopy USA, Inc.
$13
Top 3 companies account for 93.6% of total payments
Associated products mentioned in payments ›
ACCRUFER · APRISO · Aemcolo · All Products · Amitiza · BYSTOLIC · Bylvay · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · Entyvio · GATTEX · GIMOTI · HUMIRA · HYRIMOZ · Humira · IBSRELA · IDACIO · INJECTAFER · LINX Reflux Management System · LINZESS · Linzess · LiverMultiScan · MAVYRET · MOTEGRITY · MOVANTIK · Motegrity · Mulpleta · NASCOBAL · OCALIVA · OMVOH · PLENVU · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP BOWEL PREP · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS TABLETS · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for gastroenterology in TX.

Equivalent to $15,065 per 100 Medicare services performed
Looking for a gastroenterology in Dallas?
Compare gastroenterologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
251
Per 100K population
9.6
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Arslanlar is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 3%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Arslanlar experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Arslanlar performed 188 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arslanlar receive payments from pharmaceutical companies?
Yes. Dr. Arslanlar received a total of $127,747 from 43 companies across 1,055 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arslanlar's costs compare to other gastroenterologys in Dallas?
Dr. Arslanlar's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arslanlar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →